Here are five things to know:
1. Researchers used a national registry of all patients who underwent THA for osteoarthritis in Australia from 1999 through Dec. 31, 2016. They compared the outcomes of THAs performed with XLPE and those performed with conventional non-cross-linked polyethylene.
2. XLPE was used in 199,131 procedures, and CPE was used in 41,171 procedures.
3. XLPE was associated with a lower rate of revision than CPE at six months. The difference grew greater over time.
4. In the CPE group, 11.7 percent of patients underwent primary THA revision over 16 years, compared to 6.2 percent in the XLPE group.
5. The study authors suggest longevity of THA is likely to be improved, which may encourage younger patients to undergo the procedure.
More articles on surface technology:
Dr. Douglas Lucas performs ankle surgery with 3D-printed implant: 3 things to know
Stryker Spine’s Tritanium cages show bone in-growth potential in new study: 3 insights
How strategic partnerships are driving K2M’s growth and why the company isn’t afraid of 3D-printing competition
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.